Device Trial Radar · NCT02900924
Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
Last checked: Nov 20, 2026Latest source record: Apr 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Veryan Medical Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 15, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The MIMICS-3D study will evaluate safety, effectiveness and device performance within a real-world clinical population of patients undergoing femoropopliteal intervention.
Conditions
- Peripheral Arterial Disease
Interventions
BioMimics 3D StentDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Free From Major Adverse Events (MAE)Time frame: 30 days
1 more outcomes with a free account
Locations
23 sites in 4 countries. Site status is shown where the registry gives one.
OLV Hospital
Aalst, Belgium
22 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.